Which laboratory tests should be ordered for a patient with recurrent respiratory infections, chronic cough, possible allergic triggers, and a family history suggestive of cystic fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Testing for Recurrent Respiratory Infections with Family History of Cystic Fibrosis

Given the family history suggestive of cystic fibrosis combined with recurrent respiratory infections and chronic cough, you should order a sweat chloride test as the primary diagnostic test, followed by CFTR genetic testing if the sweat test is positive or intermediate. 1, 2

Essential Initial Laboratory Tests

Cystic Fibrosis Screening (Priority Testing)

  • Quantitative sweat chloride test using pilocarpine iontophoresis with collection on gauze, filter paper, or Macroduct coil 1, 3, 4
    • Values ≥60 mmol/L confirm CF diagnosis 3, 4
    • Values 30-59 mmol/L are intermediate and require extended CFTR gene analysis 3
    • Values <30 mmol/L make CF unlikely but don't completely exclude it 3
  • CFTR genetic testing should follow if sweat chloride is elevated or intermediate, particularly in children with nasal polyps or Pseudomonas colonization 1, 2

Immunodeficiency Evaluation

  • Complete blood count to assess for lymphopenia or other hematologic abnormalities 2
  • Serum immunoglobulin levels (IgG, IgA, IgM) to screen for antibody deficiency syndromes, which occur in 7% of bronchiectasis patients 2
  • Baseline specific antibody levels against Streptococcus pneumoniae capsular polysaccharides to investigate specific antibody deficiency 2
    • If low, immunize with 23-valent polysaccharide pneumococcal vaccine
    • Remeasure specific antibody levels 4-8 weeks post-vaccination 2
  • HIV-1 serology if clinical features suggest increased retroviral infection risk 2, 1

Allergic/Inflammatory Assessment

  • Serum total IgE to screen for allergic bronchopulmonary aspergillosis (ABPA) 2
  • Aspergillus-specific IgE or skin prick testing if total IgE >500 IU/mL 2
  • Nasal cytology to evaluate for allergic rhinitis, eosinophilic nonallergic rhinitis, or neutrophilic rhinitis 1

Microbiological Studies

  • Sputum cultures for routine bacterial pathogens including Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, and Burkholderia cepacia complex 2, 5
  • Mycobacterial culture (acid-fast bacilli smear and culture) from sputum if patient can expectorate 2, 6
    • Use induced sputum if spontaneous expectoration not possible 6
    • Incubate cultures for minimum 6 weeks 6

Additional Testing for Primary Ciliary Dyskinesia

Test for PCD if the patient has supporting clinical features including neonatal respiratory distress, symptoms from childhood, recurrent otitis media, rhinosinusitis, or if nasal polyps are present 3, 2

Key indicators requiring PCD evaluation: 3

  • Situs inversus with respiratory symptoms
  • Daily lifelong wet cough
  • Sibling with PCD
  • Unexplained bronchiectasis
  • Serous otitis media with lower/upper airway symptoms

Common Pitfalls to Avoid

Do not rely on oropharyngeal swabs for CF screening or mycobacterial detection—they lack sensitivity and do not provide sufficient material 6

Do not dismiss borderline sweat chloride results (30-59 mmol/L)—these require extended CFTR genetic analysis and potentially CFTR functional testing like nasal potential difference measurement 3, 4

Do not assume immunodeficiency is ruled out by normal immunoglobulin levels—functional antibody testing with pneumococcal vaccine challenge is essential to detect specific antibody deficiency 2

Be aware that transient sweat chloride elevation can occur in hypogammaglobulinemia without CF, making combined testing essential 7

Testing Sequence Algorithm

  1. First-line: Sweat chloride test + serum immunoglobulins (IgG, IgA, IgM) + total IgE + sputum culture 1, 2

  2. If sweat chloride ≥30 mmol/L: Proceed with CFTR genetic testing 3

  3. If immunoglobulins abnormal: Pneumococcal antibody levels before and after vaccination 2

  4. If total IgE >500 IU/mL: Aspergillus-specific testing 2

  5. If clinical features suggest PCD: Refer for specialized ciliary testing including electron microscopy and genetic analysis 3, 2

Related Questions

In a child with recurrent sinopulmonary infections, failure to thrive, and possible pancreatic insufficiency, what is the likelihood of cystic fibrosis and what is the next diagnostic step?
How should loose, greasy stools caused by cow's milk be managed in a cystic fibrosis patient?
How to differentiate and manage acute vs chronic cough in a patient, considering potential underlying conditions such as Chronic Obstructive Pulmonary Disease (COPD) or immunocompromised status?
In an 18‑year‑old male with cystic fibrosis, mild obstructive disease on prior spirometry and current cough with yellow‑green sputum, which is the most appropriate next test to assess disease severity: arterial blood gas analysis, repeat spirometry, chest radiograph, or chest computed tomography?
Can you explain the detailed step-by-step pathophysiology of cystic fibrosis?
Is chewing gum after a meal healthy?
Is clonidine 0.1 mg orally three times daily combined with topiramate (Topamax) 25 mg orally twice daily appropriate for treating tics?
How should an 8‑year‑old child with a persistent cough be evaluated and managed?
What is the best direct oral anticoagulant for an older adult with atrial fibrillation and diabetes mellitus?
What are the recommended steps for placing and managing a transurethral Foley catheter after a transurethral resection of the prostate (TURP) or in a patient with acute urinary retention?
How can I convert a patient from oral risperidone to a risperidone long‑acting injectable (Risperdal Consta), including appropriate dose matching and oral overlap?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.